Chronic Rhinosinusitis Treatment Study
Chronic Rhinosinusitis is a common disease which currently has limited treatment options available to patients.
Research has found that patients suffering with Chronic Rhinosinusitis using the standard nasal pump sprays have relief from some symptoms but are often left with poor results and residual symptoms. Standard nasal spray pumps have a number of weaknesses and are considered suboptimal for reliable drug delivery to target the necessary areas within the nasal sinuses to help provide symptom relief.
This clinical study is designed to evaluate the efficacy of a breath assisted mechanism of delivery. In previous clinical trials has shown to increase reliability of drug delivery within the sinuses which is central to the pathology of chronic Rhinosinusitis.
Who can participate?
You may be eligible for this study if you are:
- 18 years or older with a history of chronic rhinosinusitis
- Not currently pregnant or breastfeeding
If you are eligible to be involved in the study, you will be asked to attend the clinic 6 times over a period of approximately 6 months. This includes a run-in period of up to 3 weeks followed by a random allocation into one of three groups, each receiving a different type of medication. You will be asked to take the medication twice a day for approximately 6 months.
This study is currently looking for participants in NSW, VIC, QLD and WA.
Click here to express your interest